India's intellectual property rights regime and and price control on innovative medical devices will come up for discussions during this week's India US Trade Policy Forum meeting, the under the Trump administration.
Minister of Commerce and Industry Suresh Prabhu will arrive here tomorrow to attend the meeting with his American counterpart Wilbur Ross.
"From a US perspective, the Trade Policy Forum (TPF) will serve as a reminder that an effective intellectual property framework, coupled with a transparent legal and regulatory system, is one of the critical factors that US innovative industry evaluates when considering investing in India," Patrick Kilbride, vice president of the International Intellectual Property of the US Chambers of Commerce said.
This would be the first dialogue between the two countries on trade related issues under the Trump administration.
"This dialogue will also underscore the seriousness of growing price controls on innovative US medical devices that will not only limit quality and consumer choice, but pose a formidable barrier to entry for innovative products, in turn hurting bilateral trade ties," Kilbride said.
The International Intellectual Property of US Chambers of Commerce has the reputation of taking anti-India stand on issues related to intellectual property issues.
It has also been running anti-India campaign and protecting interest of US companies that try to sell medical products at an exorbitant price, out of reach of the common man.
This week s US-India Trade Policy Forum is likely to be outcome-driven, Kilbride also said in a email statement.
"Both sides are expected to discuss a range of market access barriers, including in manufacturing and intellectual property rights, against the backdrop of a common goal to grow bilateral trade ties from the current USD 115 billion to USD 500 billion in the next five years," he said.
(This article has not been edited by Zeebiz editorial team and is auto-generated from an agency feed.)